A 40-year-old woman developed acute myelopathy and brainstem dysfunction.
Introduction
Sjögren's syndrome (SjS) is an autoimmune disease that may be primary or secondary to other connective tissue diseases. The syndrome is characterized by mononuclear cell infiltration and the destruction of salivary and lacrimal glands, leading to xerostomia and xerophthalmia [1] . Beginning in 1980, Alexander and others published a series of reports [2] [3] [4] [5] indicating that neurological manifestations, mostly involving the peripheral nervous system (PNS), are observed in approximately 20-25% of SjS patients.
However, the exact prevalence remains controversial. Delalande et al. reported that the frequency of central nervous system (CNS) involvement by SjS is similar to that of the PNS [2] . Recently, we experienced a patient with SjS that presented with brainstem and cervical spinal cord lesions at autopsy. Here, we report this case with a description of the CNS pathology.
Case report
A 40-year-old woman developed weakness in all four limbs. Her symptoms worsened gradually for a few weeks, and she was admitted to our hospital. The patient had a history of diabetes mellitus (HbA1c 7.6%). On neurological examination, she was alert and her visual function was normal, but she had nasal voice and horizontal gaze nystagmus. She was unable to walk because of spastic tetraparesis with bilateral Babinski sign and Chaddock reflex. Muscle weakness without muscle atrophy was also revealed. (bilateral upper extremities were 4/5 of normal, and bilateral lower extremities were 3/5 of normal). Superficial sensory disturbance below the neck, parethesia of four limbs and bladder dysfunction (ischuria) were also observed. Cerebellar ataxia, optic neuritis and involuntary movement were not observed. On admission, her body temperature was 36.8 , blood pressure was 112/68 mmHg, and respiratory rate was Therefore, she was diagnosed with primary SjS according to the European Community criteria [1] [6] , and her neurological symptoms were attributed to CNS lesions caused by SjS. Therefore, 500 mg/day of methylprednisolone was given intravenously for three days as steroid pulse therapy, followed by oral prednisolone at 60 mg/day for four weeks (which was tapered at rate of 10 mg every two weeks). After steroid therapy was initiated, her symptoms improved considerably. On the 10th hospital day, her nystagmus resolved. Her spastic tetraparesis improved gradually. On the 43rd day, she became able to walk by herself with a walker. However, on day 44, she developed acute pseudo-obstruction of the colon, which induced septic shock. Although blood transfusion, antibiotic treatment and hemocatharsis were performed, she died on day 56 of multiple organ failure with hemophagocytosis. In the PNS (intracostal nerves, cauda equina and lumbar plexus), demyelination, axonal degeneration and inflammatory cell invasion were not observed. Our patient was considered to have primary SjS both clinically and pathologically, according to the criteria of the European Community [6] . We diagnosed the neurological symptoms as due to SjS.
Autopsy findings

Discussion
In this case, the clinical findings resembled those in Neuromyelitis optica (NMO) / Opticospinal multiple sclerosis (OSMS), multiple sclerosis (MS), systemic lupus erythematosis (SLE), paraneoplastic syndrome, astrocytoma, ependymoma, lymphoma, and parainfectious and postinfectious myelitis, among other conditions [7] . Primary demyelinating pathology such as MS reveals sharp, focal and complete loss of myelin [8] . On the other hand, poorly-demarcated myelin pallor was observed in our case. The pathological changes suggest the possibility of secondary demyelination differentiating from MS. The clinical findings in our case did not fulfill the criteria for SLE [9] , and our patient did not have cancer or a brain tumor. AIDS myelopathy was ruled out by the laboratory data. She was able to feed herself, and her total cholesterol, cholinesterase and Vitamin B1 were within normal ranges. Since the lack of macrocytic anemia indicated normal Vitamin B12 and folic acid levels, subacute combined degeneration of the spinal cord was ruled out.
In NMO/OSMS patients, autoantibodies involving SSA and ANA are detected occasionally [10] [11] [12] . Wang et al. [13] reported a very high prevalence (50%) of Primary Sjogren syndrome in 12 patients, who fulfilled MS criteria of both Poser et al. [14] and McDonald et al. [15] . Additionally, clinical and laboratory studies, as well as MRI findings were characteristic of OSMS rather than conventional MS. While we were unable to assay for NMO-IgG, no optic neuritis was observed and our patient did not fulfill the criteria of NMO [16] [17] . In regards to the CNS of NMO patients, pathological changes range from perivascular inflammatory demyelination to necrotic destruction of both grey and white matter [18] . Large numbers of eosinophils, polymorphonuclear cells and macrophage are often found in the inflammatory infiltrate [18] . Additionally, IgG deposits are present around vessel walls [18] . Lennon et al suggested that NMO-IgG are the primary cause of NMO through targeting of aquaporin-4 [19] . Since there was lymphocytic infiltration instead of eosinophils and no IgG deposits in the inflammatory lesions, it is unlikely that our case was NMO/OSMS.
There have been some reports examining PNS pathology in SjS patients, with vasculitis and perivascular cell invasion being the most common findings [20] [21] . However, little information is available concerning pathological changes in the CNS. In particular, there have been few descriptions of myelitis. Several reports [22] , [23] , [24] have described the CNS pathology of SjS with subsiding angitis and necrosis. On the other hand, Ichikawa et al. [25] reported that necrotic lesions with some perivascular cuffing was the ) F) G)
